共 50 条
[2]
Anderson Ryan T, 2021, Clin Gastroenterol Hepatol, V19, P463, DOI 10.1016/j.cgh.2020.05.041
[7]
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
[J].
LANCET GASTROENTEROLOGY & HEPATOLOGY,
2017, 2 (12)
:877-889